Persbericht Biocartis Group NV: Nieuwe studie toont aan dat Idylla™ EGFR Mutation Test (CE-IVD) de tijd tot beslissingen inzake patiëntenbeheer inkort voor patiënten met niet-kleincellige longkanker
16 nov. 2021 01h00 HE | Biocartis NV
PERSBERICHT: 16 november 2021, 07:00 CET Nieuwe studie toont aan dat Idylla™ EGFR Mutation Test (CE-IVD) de tijd tot beslissingen inzake patiëntenbeheer inkort voor patiënten met niet-kleincellige...
Press release Biocartis Group NV: New Study Demonstrates Idylla™ EGFR Mutation Test (CE-IVD) Shortens Time to Patient Management Decisions for Patients with Non-Small Cell Lung Cancer
16 nov. 2021 01h00 HE | Biocartis NV
PRESS RELEASE: 16 November 2021, 07:00 CET New Study Demonstrates Idylla™ EGFR Mutation Test (CE-IVD) Shortens Time to Patient Management Decisions for Patients with Non-Small Cell Lung Cancer ...
zailab.png
Zai Lab and Blueprint Medicines Announce Strategic Collaboration and License Agreement for BLU-945 and BLU-701 in Greater China
09 nov. 2021 08h00 HE | Zai Lab Limited; Blueprint Medicines
-- Zai Lab obtains exclusive rights to develop and commercialize BLU-945 and BLU-701 in Greater China -- -- Collaboration accelerates and expands global development of Blueprint Medicines’...
22157.jpg
Tyrokinse Kinase Inhibitors in the Global Oncology Market 2021: Market Leaders by Indication and Product
05 nov. 2021 05h58 HE | Research and Markets
Dublin, Nov. 05, 2021 (GLOBE NEWSWIRE) -- The "Oncology Markets for Tyrokinse Kinase Inhibitors" report has been added to ResearchAndMarkets.com's offering. Traditional cancer therapy has focused...
New guidelines provide smokers and former-smokers greater access to lung cancer screenings
02 nov. 2021 10h47 HE | Prevent Cancer Foundation
Alexandria, Va., Nov. 02, 2021 (GLOBE NEWSWIRE) -- November is Lung Cancer Awareness Month, and the Prevent Cancer Foundation® wants people to know that newly expanded access to lung cancer...
researchdrivelogo.jpg
Technological Advancements in Treatment Procedures Expected to Surge the Global Radiation Oncology Market in Upcoming Years, 2020-2027 – Exclusive Report [248 Pages] By Research Dive
25 oct. 2021 09h00 HE | Research Dive
New York, USA, Oct. 25, 2021 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global radiation oncology market is anticipated to generate a revenue of $10,679.7 million by...
TIP_link_300x300.jpg
Neoantigens Market Size ($10,54,783.54 Thousand by 2028) Growth Forecast at 31.2% CAGR During 2023 to 2028 COVID Impact and Global Analysis by TheInsightPartners.com
07 oct. 2021 10h16 HE | The Insight Partners
New York, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Neoantigens Market: Key InsightsAccording to our new research study on “Neoantigens Market to 2028 – Global Analysis and Forecast – by Treatment and...
22157.jpg
Global $892 Mn Clinical Oncology Next Generation Sequencing Markets to 2028 by Technology (WGS, WES) & Application (Screening, Companion Diagnostics)
04 oct. 2021 10h53 HE | Research and Markets
Dublin, Oct. 04, 2021 (GLOBE NEWSWIRE) -- The "Global Clinical Oncology Next Generation Sequencing Market 2021-2028" report has been added to ResearchAndMarkets.com's offering. The global clinical...
Annabelle Gurwitch and chef Amar Santana partner with Lung Cancer Foundation of America (LCFA) for Day at the Chef’s Table in support of lung cancer research
22 sept. 2021 05h03 HE | Lung Cancer Foundation of America
Los Angeles, CA, Sept. 22, 2021 (GLOBE NEWSWIRE) -- New York Times bestselling author, actor, and activist, and former Dinner and a Movie host Annabelle Gurwitch is teaming up with celebrity chef...
Straits Research Logo.png
Cancer and Allied Advancements in Chemotherapy – Straits Research
16 sept. 2021 09h00 HE | Straits Research
New York, US, Sept. 16, 2021 (GLOBE NEWSWIRE) -- The chemotherapy market is expected to grow at a compound annual growth rate (CAGR) of 10.4% in the forecast period from 2020 to 2029. The global...